Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
Obesity (Silver Spring, Md.)|January 29, 2008
Validation of a quantitative magnetic resonance method for measuring human body compositionAntonella Napolitano, Sam R Miller, Peter R Murgatroyd, et al.
Plos One|April 5, 2014
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studiesDerek J Nunez, Mark A Bush, David A Collins, et al.
Diabetes, Obesity & Metabolism|March 5, 2016
Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metforminD J Nunez, X Yao, J Lin, et al.
Plos One|October 28, 2016
A Systematic Review of Biomarkers and Risk of Incident Type 2 Diabetes: An Overview of Epidemiological, Prediction and Aetiological Research LiteratureAli Abbasi, Anna-Stina Sahlqvist, Luca Lotta, et al.
Frontiers in Oncology|August 23, 2021
Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic ImplicationsAndrea Comba, Syed M Faisal, Maria Luisa Varela, et al.
Plos One|January 18, 2017
DNA Metabarcoding of Amazonian Ichthyoplankton SwarmsM E Maggia, Y Vigouroux, J F Renno, et al.
Diabetes Care|September 27, 2012
Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetesSunder Mudaliar, Debra A Armstrong, Annie A Mavian, et al.
BMC Pharmacology & Toxicology|May 15, 2013
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitusAnita Kapur, Robin O'Connor-Semmes, Elizabeth K Hussey, et al.
BMJ Open|August 9, 2020
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trialDagmar F Hernandez-Suarez, Kyle Melin, Frances Marin-Maldonado, et al.
Heart (British Cardiac Society)|April 3, 2008
Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascadeV Bodi, J Sanchis, M P Lopez-Lereu, et al.
Pageof 24